Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Ono and OncoTherapy enter license agreement for therapeutic peptide vaccines for cancer

March 29, 2011

MolMed and Fondazione Telethon agree to develop gene therapy for six rare diseases

March 29, 2011

Ariad and MolecularMD collaborate on companion T315I mutation diagnostic test

March 29, 2011

AltheRx acquires solabegron from GSK

March 28, 2011

Cilag to market Pozen's antimigraine treatment MT-400 in parts of South America

March 25, 2011

Ambrilia Biopharma enters into agreement with ZBx for PSP-94

March 24, 2011

Cellular Dynamics and Roche form standard supply agreement for iCell Cardiomyocytes

March 24, 2011

Asahi Kasei obtains exclusive rights to Xiaflex for two indications in Japan

March 23, 2011

Tesaro acquires rights to Amgen's anaplastic lymphoma kinase program

March 23, 2011

Seattle Genetics forms antibody-drug conjugate collaboration with Abbott

March 23, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...